These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9109532)

  • 1. Corticotropin-releasing factor (CRF), CRF-binding protein (CRF-BP), and CRF/CRF-BP complex in Alzheimer's disease and control postmortem human brain.
    Behan DP; Khongsaly O; Owens MJ; Chung HD; Nemeroff CB; De Souza EB
    J Neurochem; 1997 May; 68(5):2053-60. PubMed ID: 9109532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urocortin interaction with corticotropin-releasing factor (CRF) binding protein (CRF-BP): a novel mechanism for elevating "free' CRF levels in human brain.
    Behan DP; Khongsaly O; Ling N; De Souza EB
    Brain Res; 1996 Jul; 725(2):263-7. PubMed ID: 8836534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of corticotropin-releasing factor (CRF), CRF-binding protein (CRF-BP), and CRF/CRF-BP complex in human plasma by two-site enzyme-linked immunoabsorbant assay.
    Behan DP; Khongsaly O; Liu XJ; Ling N; Goland R; Nasman B; Olsson T; De Souza EB
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2579-86. PubMed ID: 8675581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand requirements of the human corticotropin-releasing factor-binding protein.
    Sutton SW; Behan DP; Lahrichi SL; Kaiser R; Corrigan A; Lowry P; Potter E; Perrin MH; Rivier J; Vale WW
    Endocrinology; 1995 Mar; 136(3):1097-102. PubMed ID: 7867564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Displacement of corticotropin releasing factor from its binding protein as a possible treatment for Alzheimer's disease.
    Behan DP; Heinrichs SC; Troncoso JC; Liu XJ; Kawas CH; Ling N; De Souza EB
    Nature; 1995 Nov; 378(6554):284-7. PubMed ID: 7477348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 125I-Antisauvagine-30: a novel and specific high-affinity radioligand for the characterization of corticotropin-releasing factor type 2 receptors.
    Higelin J; Py-Lang G; Paternoster C; Ellis GJ; Patel A; Dautzenberg FM
    Neuropharmacology; 2001; 40(1):114-22. PubMed ID: 11077077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signaling properties of mouse and human corticotropin-releasing factor (CRF) receptors: decreased coupling efficiency of human type II CRF receptor.
    Xiong Y; Xie LY; Abou-Samra AB
    Endocrinology; 1995 May; 136(5):1828-34. PubMed ID: 7720627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different binding modes of amphibian and human corticotropin-releasing factor type 1 and type 2 receptors: evidence for evolutionary differences.
    Dautzenberg FM; Py-Lang G; Higelin J; Fischer C; Wright MB; Huber G
    J Pharmacol Exp Ther; 2001 Jan; 296(1):113-20. PubMed ID: 11123370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reciprocal changes in corticotropin-releasing factor (CRF)-like immunoreactivity and CRF receptors in cerebral cortex of Alzheimer's disease.
    De Souza EB; Whitehouse PJ; Kuhar MJ; Price DL; Vale WW
    Nature; 1986 Feb 13-19; 319(6054):593-5. PubMed ID: 3003585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of the human plasma corticotrophin-releasing factor-binding protein.
    Behan DP; Linton EA; Lowry PJ
    J Endocrinol; 1989 Jul; 122(1):23-31. PubMed ID: 2549150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five amino acids of the Xenopus laevis CRF (corticotropin-releasing factor) type 2 receptor mediate differential binding of CRF ligands in comparison with its human counterpart.
    Dautzenberg FM; Higelin J; Brauns O; Butscha B; Hauger RL
    Mol Pharmacol; 2002 May; 61(5):1132-9. PubMed ID: 11961131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticotropin-releasing factor-binding protein is a glycoprotein.
    Suda T; Sumitomo T; Tozawa F; Ushiyama T; Demura H
    Biochem Biophys Res Commun; 1989 Dec; 165(2):703-7. PubMed ID: 2597157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticotropin releasing factor (CRF) binding protein: a novel regulator of CRF and related peptides.
    Behan DP; De Souza EB; Lowry PJ; Potter E; Sawchenko P; Vale WW
    Front Neuroendocrinol; 1995 Oct; 16(4):362-82. PubMed ID: 8557170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping of the ligand-selective domain of the Xenopus laevis corticotropin-releasing factor receptor 1: implications for the ligand-binding site.
    Dautzenberg FM; Wille S; Lohmann R; Spiess J
    Proc Natl Acad Sci U S A; 1998 Apr; 95(9):4941-6. PubMed ID: 9560207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The alternatively spliced type II corticotropin-releasing factor receptor, stably expressed in LLCPK-1 cells, is not well coupled to the G protein(s).
    Nabhan C; Xiong Y; Xie LY; Abou-Samra AB
    Biochem Biophys Res Commun; 1995 Jul; 212(3):1015-21. PubMed ID: 7626087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding differences of human and amphibian corticotropin-releasing factor type 1 (CRF(1)) receptors: identification of amino acids mediating high-affinity astressin binding and functional antagonism.
    Dautzenberg FM; Wille S
    Regul Pept; 2004 May; 118(3):165-73. PubMed ID: 15003833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropeptides in Alzheimer's disease: a postmortem study.
    Nemeroff CB; Kizer JS; Reynolds GP; Bissette G
    Regul Pept; 1989 Apr; 25(1):123-30. PubMed ID: 2566190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological characterisation of the recombinant human CRF binding protein using a simple assay.
    Ardati A; Gottowik J; Henriot S; Clerc RG; Kilpatrick GJ
    J Neurosci Methods; 1998 Mar; 80(1):99-105. PubMed ID: 9606055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of amino acids in the N-terminal domain of corticotropin-releasing factor receptor 1 that are important determinants of high-affinity ligand binding.
    Wille S; Sydow S; Palchaudhuri MR; Spiess J; Dautzenberg FM
    J Neurochem; 1999 Jan; 72(1):388-95. PubMed ID: 9886092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of corticotropin-releasing factor binding protein-immunoreactivity in the rat hypothalamus: association with corticotropin-releasing factor-, urocortin 1- and vimentin-immunoreactive fibres.
    Henry BA; Lightman SL; Lowry CA
    J Neuroendocrinol; 2005 Mar; 17(3):135-44. PubMed ID: 15796765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.